Related Experiment Video
Updated: Jun 18, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Claudin-5 as a novel estrogen target in vascular endothelium
Malgorzata Burek1, Paula A Arias-Loza, Norbert Roewer
1Department of Anaesthesia and Critical Care, Institute of Anatomy and Cell Biology, University of Würzburg, Würzburg, Germany. Burek_M@klinik.uni-wuerzburg.de
Objective:
Estrogens have multiple effects on vascular physiology and function. In the present study, we look for direct estrogen target genes within junctional proteins.
Methods And Results:
We use murine endothelial cell lines of brain and heart origin, which express both subtypes of estrogen receptor, ERalpha and ERbeta. Treatment of these cells with 17beta-estradiol (E2) led to an increase in transendothelial electric resistance and a most prominent upregulation of the tight junction protein claudin-5 expression. A significant increase of claudin-5 promoter activity, mRNA, and protein levels was detected in cells from both vascular beds. In protein lysates and in immunoreactions on brain sections from ovariectomized E2-treated mice, we noticed an increase in claudin-5 protein and mRNA content. Treatment of cells with a specific ERbeta agonist, diarylpropionitrile, revealed the same effect as E2 stimulation. Moreover, we detected significantly lower claudin-5 mRNA and protein content in ERbeta knockout mice.
Conclusions:
We describe claudin-5 as a novel estrogen target in vascular endothelium and show in vivo (brain endothelium) and in vitro (brain and heart endothelium) effects of estrogen on claudin-5 levels. The estrogen-induced increase in junctional protein levels may lead to an improvement in vascular structural integrity and barrier function of vascular endothelium.
Insights
Estrogen directly targets claudin-5, a key junctional protein in brain and heart endothelial cells. This estrogen-induced increase in claudin-5 enhances vascular barrier function.
Area of Science:
- Endocrinology
- Vascular Biology
- Molecular Biology
Background:
- Estrogens significantly influence vascular physiology and function.
- Identifying direct estrogen targets in vascular endothelium is crucial for understanding its roles.
Purpose of the Study:
- To identify direct estrogen target genes within junctional proteins.
- To investigate the role of estrogens in regulating claudin-5 expression in endothelial cells.
Main Methods:
- Utilized murine endothelial cell lines (brain and heart) expressing estrogen receptors (ERalpha and ERbeta).
- Treated cells with 17beta-estradiol (E2) and an ERbeta agonist (diarylpropionitrile).
- Analyzed claudin-5 promoter activity, mRNA, and protein levels in vitro and in vivo (ovariectomized mice, ERbeta knockout mice).
Main Results:
- 17beta-estradiol upregulated claudin-5 expression, promoter activity, mRNA, and protein levels in brain and heart endothelial cells.
- In vivo studies confirmed increased claudin-5 in E2-treated mice and decreased levels in ERbeta knockout mice.
- ERbeta activation mimicked E2 effects, indicating ERbeta's role in mediating claudin-5 regulation.
Conclusions:
- Claudin-5 is identified as a novel direct estrogen target gene in vascular endothelium.
- Estrogen administration increases claudin-5 levels in brain and heart endothelium, both in vitro and in vivo.
- Elevated claudin-5 may enhance vascular structural integrity and barrier function.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Tight Junctions
Mechanism of Angiogenesis
Secondary Messengers in Hormone Action
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
Regulation of Hormone Secretion
Humoral stimuli,...
Endocrine Signaling

